Increased resistance rate to ceftazidime among blood culture isolates of ESBL-producing Escherichia coli in a university-affiliated hospital of China

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Angus, D. C., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303–1310 (2001).

    CAS  Article  Google Scholar 

  2. 2

    Knudsen, J. D. & Andersen, S. E. Bispebjerg Intervention Group. A multidisciplinary intervention to reduce infections of ESBL-and AmpC-producing, gram-negative bacteria at a University Hospital. PLoS ONE 9, e86457 (2014).

    Article  Google Scholar 

  3. 3

    Rupp, M. E. & Fey, P. D. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 63, 353–365 (2003).

    CAS  Article  Google Scholar 

  4. 4

    Xia, S., et al. Dominance of CTX-M-type extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China. PLoS ONE 9, e100707 (2014).

    Article  Google Scholar 

  5. 5

    Bonnet, R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48, 1–14 (2004).

    CAS  Article  Google Scholar 

  6. 6

    Poirel, L., Gniadkowski, M. & Nordmann, P. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. J. Antimicrob. Chemother. 50, 1031–1034 (2002).

    CAS  Article  Google Scholar 

  7. 7

    Bonnet, R., et al. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240—>Gly. Antimicrob. Agents Chemother. 45, 2269–2275 (2001).

    CAS  Article  Google Scholar 

  8. 8

    Kiratisin, P., et al. The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand. Diagn. Microbiol. Infect. Dis. 58, 349–355 (2007).

    CAS  Article  Google Scholar 

  9. 9

    Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing; CLSI Document M100-S20, Clinical and Laboratory Standards Institute, Wayne, PA, (2010).

  10. 10

    Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing; 23rd Informational Supplement. CLSI Document M100-S22, Clinical and Laboratory Standards Institute, Wayne, PA, (2012).

  11. 11

    Shannon, K. P., King, A., Phillips, I., Nicolas, M. H. & Philippon, A. Importance of organisms producing broad-spectrum SHV-group beta-lactamases into the United Kingdom. J. Antimicrob. Chemother. 25, 343–351 (1990).

    CAS  Article  Google Scholar 

  12. 12

    Lee, J. H., Bae, I. K. & Lee, S. H. New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance. Med. Res. Rev. 32, 216–232 (2012).

    CAS  Article  Google Scholar 

  13. 13

    Liu, W., et al. Novel CTX-M {beta}-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China. J. Antimicrob. Chemother. 63, 895–900 (2009).

    CAS  Article  Google Scholar 

  14. 14

    Feng, X., et al. Escherichia coli Peritonitis in peritoneal dialysis: the prevalence, antibiotic resistance and clinical outcomes in a South China dialysis center. Perit. Dial. Int. 34, 308–316 (2014).

    CAS  Article  Google Scholar 

  15. 15

    Rodríguez-Baño, J . et al. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin. Infect. Dis. 43, 1407–1414 (2006).

    Article  Google Scholar 

  16. 16

    An, S., et al. Predominant characteristics of CTX-M-producing Klebsiella pneumoniae isolates from patients with lower respiratory tract infection in multiple medical centers in China. FEMS Microbiol. Lett. 332, 137–145 (2012).

    CAS  Article  Google Scholar 

  17. 17

    Zhuo, C., Li, X. Q., Zong, Z. Y. & Zhong, N. S. Epidemic plasmid carrying bla(CTX-M-15) in Klebsiella penumoniae in China. PLoS ONE 8, e52222 (2013).

    CAS  Article  Google Scholar 

  18. 18

    Baraniak, A ., Fiett, J., Hryniewicz, W., Nordmann, P. & Gniadkowski, M. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland. J. Antimicrob. Chemother. 50, 393–396 (2002).

    CAS  Article  Google Scholar 

  19. 19

    Zhang, J., et al. Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals. BMC Infect. Dis. 14, 659 (2014).

    Article  Google Scholar 

  20. 20

    He, D., et al. CTX-M-123, a novel hybrid of the CTX-M-1 and CTX-M-9 Group β-lactamases recovered from Escherichia coli isolates in China. Antimicrob. Agents Chemother. 57, 4068–4071 (2013).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Science and Technology Major Project of China (2013ZX10004217).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Xiao-Yan Yuan.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yuan, X., Yu, D., Qu, X. et al. Increased resistance rate to ceftazidime among blood culture isolates of ESBL-producing Escherichia coli in a university-affiliated hospital of China. J Antibiot 69, 169–172 (2016). https://doi.org/10.1038/ja.2015.100

Download citation

Further reading